Prevention and Treatment of Postoperative Pulmonary Complications in Elderly Patients with Lung Cancer and Esophageal Cancer

This research aims to investigate strategies for mitigating and treating post-surgical lung complications among patients suffering from lung and esophageal cancers. In this study, 50 senior patients diagnosed with lung and esophageal cancers who underwent surgical tumor removal at our institution between September 2022 and January 2024 were utilized as research subjects. Employing a numerical blind assignment technique, these patients were segregated into two groups: one consisting of 25 patients receiving standard care (control group), and the other comprising 25 patients subjected to specialized care aimed at preventing pulmonary complications (observation group). A comparative analysis was conducted to evaluate clinical metrics, life quality, and the prevalence of pulmonary complications among the groups. Results: Metrics such as the duration of rehabilitation and the rate of pulmonary complications were found to be significantly improved in the control group compared to initial expectations, as evidenced by statistical significance (P<0.05). Furthermore, the life quality evaluations revealed that the observation group achieved superior outcomes relative to the control group (P<0.05). Therapeutic interventions targeting pulmonary complications have been shown to significantly mitigate the decline in postoperative lung function in elderly individuals diagnosed with lung and esophageal cancers, enhancing their recuperation rates and substantially improving their life quality. Consequently, such treatments are recommended for broader clinical adoption.